Veracyte (VCYT) Net Cash Flow Growth (1y) (2013 - 2026)
Veracyte (VCYT) Net Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -298.36% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -7,202.13% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 665.15% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 117.44% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 722.22% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -320.00% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -58.16% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -1,722.22% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -273.33% |
| 10 | Veracyte | 3.84 Bn | 3.58 Bn | 101.16 Mn | -87.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.71% |
| Dec 31, 2025 | 237.73% |
| Sep 30, 2025 | 152.56% |
| Jun 30, 2025 | 22.47% |
| Mar 31, 2025 | -661.51% |
| Dec 31, 2024 | -349.10% |
| Sep 30, 2024 | 231.13% |
| Jun 30, 2024 | 99.97% |
| Mar 31, 2024 | -129.47% |
| Dec 31, 2023 | 182.55% |
| Sep 30, 2023 | -33.72% |
| Jun 30, 2023 | 237.50% |
| Mar 31, 2023 | 352.74% |
| Dec 31, 2022 | -284.33% |
| Sep 30, 2022 | 110.58% |
| Jun 30, 2022 | -284.56% |
| Mar 31, 2022 | 62.89% |
| Dec 31, 2021 | 110.18% |
| Sep 30, 2021 | -182.80% |
| Jun 30, 2021 | 192.93% |